To Evaluate Pharmacokinetics and Pharmacodynamics of Z-215 in Healthy Male Subjects
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate pharmacokinetics and pharmacodynamics of Z-215 (10
mg, 20 mg, 40 mg) , compared with Rabeprazole Sodium (10 mg, 20 mg ) in Healthy Male
Subjects. And to evaluate food-effect in Healthy Male Subjects administrated Z-215 20 mg.